Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Sirona Biochem Corp V.SBM

Alternate Symbol(s):  SRBCF

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to... see more

TSXV:SBM - Post Discussion

Sirona Biochem Corp > Skinmedica
View:
Post by Turtle4 on Oct 14, 2024 11:36am

Skinmedica

Does anyone know if Skinmedica is also represented outside the USA?
The Skinmedia online store only delivers to the USA.
In the quarterly reports, “Other Aesthetics” makes almost all of its sales in the USA.
That would mean that the worldwide license is pointless.
Probably no milestone payment is triggered if a reseller sells the product outside the USA.
 
I had hoped that skinmedica might not want to miss out on the Christmas business after all and still launch this year.
But if there are no multiple milestone payments for other countries, the payment could turn out to be as small as the upfront.
Comment by gr0und1ng on Oct 14, 2024 7:00pm
...the first milestone payment will be tied to the first commercial sale of each product in a certain geographic market. For example if they launch a skin lightener cream in the US that will be a milestone payment plus a royalty on the sale. If they launch in Canada at the same time, that's another milestone payment and the royalties also start at the point. If they launch a crme and a serum ...more  
Comment by tylerreddick on Oct 14, 2024 7:29pm
Well, Abbvie hasn't launched sweet fark all to date. But it appears they aren't telling Howie anything, so who knows, we may get a big surprise one day (not holding my breath on that one)
Comment by Turtle4 on Oct 15, 2024 3:39am
Yes, I know that. That's why I asked how many geographic markets Skinmedica is active on. So far I only know about the USA and Canada. And in Canada there is only a very limited offer (see skinmedica.ca)
Comment by tylerreddick on Oct 15, 2024 10:20am
Skinmedica appears to be aimed at a different market, a more upscale market, than what Howie appears to be targeting. And considering Abbvie's products, I continue to doubt they give us anything but scraps. So we are back to waiting for the launch of GPM, and all of the news releases that come leading up to that.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities